Funded Tech Companies
Tune Therapeutics
Looking for the VC firms that invested in Tune Therapeutics? Regeneron Pharmaceuticals, Yosemite and New Enterprise Associates invested in this innovative biopharmaceutical company.
Company Overview
Company Name
Tune Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1616 Eastlake Ave. East
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Tune Therapeutics, Inc. is orchestrating the power of the epigenome to treat complex, pervasive diseases that have long eluded treatment. With its versatile and powerful TEMPO epigenomic control platform, Tune's experienced team is pioneering a new therapeutic modality that can fine-tune any gene network.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/13/2025
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Kane
Chief Scientific Officer
Charles Gersbach
Co-Founder
Fyodor Urnov
Executive Vice President
Heidi Zhang
President
Akira Matsuno
VP - R & D
Blythe Sather
Company Investors
- Regeneron Pharmaceuticals
- Yosemite
- New Enterprise Associates
- Hatteras Venture Partners
- Mission BioCapital
- Emerson Collective
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs